TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32162503

Group type: EXPERIMENTAL
Intervention: Continuous countermovement jumping
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intermittent countermovement jumping
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 36138375

Group type: EXPERIMENTAL
Intervention: Health4Me text message program (4-5 messages per week for 6 months)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 330
Study: 32651998

Group type: EXPERIMENTAL
Intervention: Higher Dietary Diversity Score (DDS)
Number of subjects: 7553

Group type: EXPERIMENTAL
Intervention: Higher Prime Diet Quality Score (PDQS)
Number of subjects: 7553
Study: 34301324

Group type: EXPERIMENTAL
Intervention: The Knack
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: PFMT
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: The Knack + PFMT
Number of subjects: 210
Study: 32439861

Group type: EXPERIMENTAL
Intervention: Synchronized drumming
Number of subjects: 153

Group type: COMPARATOR
Intervention: Asynchronized drumming
Number of subjects: 153
Study: 35396175

Group type: EXPERIMENTAL
Intervention: Supervised, individualised exercise program (60-minute sessions, 2-3 sessions/week for 12 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Home-based exercise program (30-minute sessions, 2-3 sessions/week for 12 weeks)
Number of subjects: 16
Study: 32860843

Group type: EXPERIMENTAL
Intervention: LBBP
Number of subjects: 84

Group type: COMPARATOR
Intervention: RVOP
Number of subjects: 84
Study: 32220093

Group type: EXPERIMENTAL
Intervention: Type 1 statins (simvastatin, lovastatin, pravastatin)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Type 2 statins (atorvastatin, rosuvastatin)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 284
Study: 32694287

Group type: EXPERIMENTAL
Intervention: Strength training and ankle mobility program (n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Strength training only (n = 9)
Number of subjects: 20
Study: 33657337

Group type: EXPERIMENTAL
Intervention: Desire to feel better and have more energy
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Desire to maintain health
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Moderate routine physical activity levels
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: High routine physical activity levels
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Busy lifestyle as a barrier
Number of subjects: 322
Study: 32745598

Group type: EXPERIMENTAL
Intervention: Family Focused Therapy for High-Risk Youth (FFT-HR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 34
Study: 35581710

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transversus abdominis plane (TAP) block
Number of subjects: 60
Study: 33725579

Group type: EXPERIMENTAL
Intervention: Deep learning model combining clinical features and multi-scale histopathologic and radiomic image features
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Clinical features only
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) only
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pathological images only
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: MRI plus pathology
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: MRI plus clinical
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pathology plus clinical
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Combination of clinical, MRI, and pathology features
Number of subjects: 109
Study: 36306175

Group type: EXPERIMENTAL
Intervention: Education plus exercise
Number of subjects: 204

Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 204

Group type: COMPARATOR
Intervention: Wait and see
Number of subjects: 204
Study: 32938875

Group type: COMPARATOR
Intervention: 11 English-language symptom checkers
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: Virtual patient encounters
Number of subjects: 574
Study: 35589134

Group type: EXPERIMENTAL
Intervention: CLO view (60°±5°)
Number of subjects: 79

Group type: COMPARATOR
Intervention: LAT view
Number of subjects: 79
Study: 32402630

Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) combined with rehabilitation exercise
Number of subjects: 109

Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both groups (CDT and Control)
Number of subjects: 109
Study: 33272841

Group type: EXPERIMENTAL
Intervention: Short-duration high-intensity exercise (HIE) for 20 min at 70%–80% heart rate reserve (HRR)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Long-duration low-intensity exercise (LIE) for 60 min at 30%–40% HRR
Number of subjects: 42
Study: 33079070

Group type: EXPERIMENTAL
Intervention: Digital therapeutic intervention plus usual care
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 50
Study: 35659695

Group type: EXPERIMENTAL
Intervention: Universal process-based CBT intervention (six sessions)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 604
Study: 34937145

Group type: EXPERIMENTAL
Intervention: Remdesivir (200 mg on day 1 and 100 mg on days 2 and 3)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 562
Study: 32278106

Group type: EXPERIMENTAL
Intervention: Continuous Suture Group
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Interrupted Cutaneous Suture Group
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Interrupted Subcutaneous Suture Group
Number of subjects: 183

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 183
Study: 34487147

Group type: EXPERIMENTAL
Intervention: Laparoscopic pylorus-preserving gastrectomy (LPPG)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Laparoscopic distal gastrectomy (LDG)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Both groups (LPPG and LDG)
Number of subjects: 256
Study: 33159033

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (IN‐OT) treatment (24 IU daily for 4 weeks)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Multiple-dose IN‐OT treatment (24 IU daily for 4 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study: 32991355

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg/d
Number of subjects: 96

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 96
Study: 32814339

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT) for 3 months, 3 times per week on a GalileoTM vibration plate at 6-20 Hz
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control training group (CTG) performing sham WBV training
Number of subjects: 26
Study: 32978034

Group type: EXPERIMENTAL
Intervention: Cognition for Learning and for Understanding Everyday Social Situations (CLUES)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Enriched Acceptance and Commitment Therapy (EnACT)
Number of subjects: 38
Study: 35360942

Group type: EXPERIMENTAL
Intervention: Prophylactic fixation
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Surgical technique of open reduction and internal fixation
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Inability to walk at presentation
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Untreated opposite hips
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Age under 12.5 years
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Surgical strategy variation
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Patient-reported outcome measures (PROMs)
Number of subjects: 486
Study: 33678038

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention administered by an unblinded nurse falls care manager
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revised primary outcome definition (Types 1 and 2a)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original primary outcome definition (Types 1, 2a, and 2b)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 0
Study: 35617770

Group type: EXPERIMENTAL
Intervention: Central adiposity (WC > 88 cm)
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Central adiposity (WHR > 0.8)
Number of subjects: 621
Study: 33152350

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IVM
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IVM/IVF
Number of subjects: 22
Study: 32928140

Group type: EXPERIMENTAL
Intervention: Enhanced ED-centered recruitment strategy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard recruitment strategy (pre-enhancement)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Total recruitment period
Number of subjects: 120
Study: 33453489

Group type: EXPERIMENTAL
Intervention: Infants born before 28 weeks GA
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Infants with late-onset septicaemia (LOS)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Infants with bronchopulmonary dysplasia (BPD)
Number of subjects: 74

Group type: COMPARATOR
Intervention: VLBW infants
Number of subjects: 74
Study: 32063029

Group type: EXPERIMENTAL
Intervention: New experimental arms added to ongoing trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing control arm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Šidák’s correction
Number of subjects: 0
Study: 33257497

Group type: EXPERIMENTAL
Intervention: Active treatment group
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 354
Study: 32879436

Group type: EXPERIMENTAL
Intervention: DSC2U (Down Syndrome Clinic to You)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study: 36366791

Group type: EXPERIMENTAL
Intervention: Teach-Back intervention (TIME)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 107
Study: 34881935

Group type: EXPERIMENTAL
Intervention: LCT/CBT
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Avoid/CBT
Number of subjects: 123

Group type: COMPARATOR
Intervention: WL/TAU
Number of subjects: 123
Study: 35313936

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.25% bupivacaine (total 50 mg) for bilateral ultrasound-guided rectus sheath block (URSB)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no sham block)
Number of subjects: 66
Study: 33580845

Group type: EXPERIMENTAL
Intervention: Glutamine (4 g twice daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (glycine, 4 g twice daily)
Number of subjects: 53
Study: 36175252

Group type: EXPERIMENTAL
Intervention: Triple-bundle anterior cruciate ligament reconstruction
Number of subjects: 25

Group type: COMPARATOR
Intervention: Double-bundle anterior cruciate ligament reconstruction
Number of subjects: 25
Study: 33393638

Group type: EXPERIMENTAL
Intervention: Multimodal inpatient rehabilitation with workplace intervention
Number of subjects: 175

Group type: COMPARATOR
Intervention: Standard inpatient occupational rehabilitation without workplace intervention
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: High or medium self-efficacy scores
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Consistently high or increasing self-efficacy scores
Number of subjects: 175
Study: 33584534

Group type: EXPERIMENTAL
Intervention: Gabby (online conversational agent)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group (letter listing preconception risks)
Number of subjects: 480
Study: 33558360

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Colesevelam (Bile Acid Sequestrant)
Number of subjects: 50
Study: 32065857

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pralatrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Romidepsin
Number of subjects: 0
Study: 35266279

Group type: EXPERIMENTAL
Intervention: Self-Reflection Resilience Training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 68
Study: 32293314

Group type: EXPERIMENTAL
Intervention: Residential Care Transition Module (RCTM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 240
Study: 35381657

Group type: EXPERIMENTAL
Intervention: Psychological suggestion combined with rational diet therapy
Number of subjects: 181

Group type: COMPARATOR
Intervention: Routine dietary guidance and health education (Control)
Number of subjects: 181
Study: 34313371

Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg b.i.d.
Number of subjects: 43
Study: 34085547

Group type: EXPERIMENTAL
Intervention: Warm distension fluid (37°C)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Room temperature fluid (25°C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 33037609

Group type: EXPERIMENTAL
Intervention: Medium NaCl (0.4 g/100 mL) + 29 mM MSG
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Low NaCl (0.2 g/100 mL) + 29 mM MSG
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control broth (0 g NaCl, 0 g MSG)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: High NaCl broth (0.8 g/100 mL)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Medium NaCl (0.4 g/100 mL)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Low NaCl (0.2 g/100 mL)
Number of subjects: 115
Study: 33938708

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment after dermabrasion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dinoprostone gel after dermabrasion
Number of subjects: 40
Study: 34233907

Group type: EXPERIMENTAL
Intervention: Volume guarantee (VG)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Volume controlled ventilation (VCV)
Number of subjects: 19
Study: 34670544

Group type: EXPERIMENTAL
Intervention: Microthreaded implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Threaded implants
Number of subjects: 30
Study: 32401221

Group type: EXPERIMENTAL
Intervention: Videoconference follow-up
Number of subjects: 120

Group type: COMPARATOR
Intervention: Telephone follow-up
Number of subjects: 120
Study: 34474088

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) therapy
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory agents
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1627
Study: 32998775

Group type: EXPERIMENTAL
Intervention: Bupivacaine lavage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diclofenac suppository
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 34467629

Group type: EXPERIMENTAL
Intervention: Education pack to clean umbilicus prior to surgery
Number of subjects: 62

Group type: COMPARATOR
Intervention: No education pack (control group)
Number of subjects: 62
Study: 32624366

Group type: EXPERIMENTAL
Intervention: Light transmittance aggregometry (LTA)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Thromboelastography (TEG)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Platelet function analyzer (PFA)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control group (clopidogrel users)
Number of subjects: 249
Study: 35272779

Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound (IVUS) guidance
Number of subjects: 150

Group type: COMPARATOR
Intervention: Angiographic guidance alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound (IVUS) guidance with drug-coated balloons
Number of subjects: 150

Group type: COMPARATOR
Intervention: Angiographic guidance with drug-coated balloons
Number of subjects: 150
Study: 33397768

Group type: COMPARATOR
Intervention: Dulaglutide 4.5 mg
Number of subjects: 1842

Group type: COMPARATOR
Intervention: Dulaglutide 3.0 mg
Number of subjects: 1842

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 1842
Study: 34287760

Group type: EXPERIMENTAL
Intervention: Long-term absorbable suture (MonoPlus®) - Group I
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Long-term absorbable suture and onlay mesh reinforcement - Group II
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Extra long-term absorbable suture (MonoMax®) - Group III
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (Primary suture)
Number of subjects: 104
Study: 34386735

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 50 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Dapagliflozin vs Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Dapagliflozin and Placebo
Number of subjects: 15
Study: 35250807

Group type: EXPERIMENTAL
Intervention: Suprasensory RPSS (one session)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsensory RPSS (one session)
Number of subjects: 0
Study: 33082245

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 2139
Study: 35263104

Group type: EXPERIMENTAL
Intervention: Diet based on crops fertilized with animal manure
Number of subjects: 33

Group type: COMPARATOR
Intervention: Synthetic fertilizer
Number of subjects: 33
Study: 35259523

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reading/listening intervention (READ)
Number of subjects: 68
Study: 32755236

Group type: EXPERIMENTAL
Intervention: Retrospective recall of 90‐day modified Rankin Scale at 6, 9, or 12 months after hospital discharge
Number of subjects: 0
Study: 34281014

Group type: EXPERIMENTAL
Intervention: Live-Performed Music Therapy (LPMT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 45
Study: 36380186

Group type: EXPERIMENTAL
Intervention: B. clausii (oral suspension, total dose 4 billion spores/day)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: B. clausii
Number of subjects: 259

Group type: COMPARATOR
Intervention: B. clausii and Placebo
Number of subjects: 259
Study: 32224739

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) at a dose of 15 mg/kg
Number of subjects: 5698

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 5698

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 5698
Study: 32595959

Group type: EXPERIMENTAL
Intervention: Temporal processing-based auditory training program (36 sessions over three months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 36301983

Group type: EXPERIMENTAL
Intervention: standard care + online parent training
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: standard care + face-to-face parent training
Number of subjects: 90

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 90
Study: 34932280

Group type: EXPERIMENTAL
Intervention: Mexidol intravenously 500 mg once daily for 14 days, followed by Mexidol FORTE 250 - 250 mg 3 times a day orally for 60 days
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study: 34399839

Group type: EXPERIMENTAL
Intervention: Polyvinyl chloride foil containing an integrated silver-based agent (2% silver ions) applied to high-touch surfaces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard cleaning and disinfection)
Number of subjects: 0
Study: 33228714

Group type: EXPERIMENTAL
Intervention: HOGO system (EMF-insulated bed) for 2 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo group (bed without EMF insulation)
Number of subjects: 31
Study: 36353150

Group type: EXPERIMENTAL
Intervention: Auricular point acupressure (APA), applied 4 times/day for three weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study: 32472804

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard fluid therapy
Number of subjects: 283
Study: 36378780

Group type: EXPERIMENTAL
Intervention: Udenafil (87.5 mg po BID)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 32795214

Group type: EXPERIMENTAL
Intervention: Ongoing medicine randomized controlled trials (RCTs) in Europe
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Ongoing medicine randomized controlled trials (RCTs) in the USA
Number of subjects: 106

Group type: COMPARATOR
Intervention: European trials
Number of subjects: 106

Group type: COMPARATOR
Intervention: USA trials
Number of subjects: 106

Group type: COMPARATOR
Intervention: Multicenter trials in Europe
Number of subjects: 106

Group type: COMPARATOR
Intervention: Multicenter trials in the USA
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Masked RCTs in the USA
Number of subjects: 106

Group type: COMPARATOR
Intervention: Masked RCTs in Europe
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: RCTs on hospitalized patients in Europe
Number of subjects: 106

Group type: COMPARATOR
Intervention: RCTs on hospitalized patients in the USA
Number of subjects: 106
Study: 35881067

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Baseline fatigue levels
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Baseline emotional functioning
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Previous exercise habits
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Psychosocial support
Number of subjects: 446
Study: 33594278

Group type: EXPERIMENTAL
Intervention: Scheduled low-dose memory (CD45RA-depleted) donor lymphocyte infusion (mDLI)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Total cohort
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Memory DLI
Number of subjects: 149